Just - Evotec Biologics

⚕️Avec l’installation du centre de développement et de fabrication de biotechnologies, le J.POD d’Evotec, Toulouse s’inscrit comme une référence internationale dans le domaine de la santé. 💊 Cette usine innovante, la 1ère en Europe, est chargée de la fabrication de produits thérapeutiques et des biomédicaments du futur à destination des acteurs de l’industrie pharmaceutique et biotechnologique. 🏥 L'ingénierie de pointe derrière ce projet et les avancées qu'il représente sont essentiels pour bâtir la santé du futur, pour laquelle nous nous battons depuis plusieurs années. 🙏 Un grand merci à toute l'équipe pour l'accueil ! #Toulouse #Santé #Industrie #Progrès #Biomedicament

Check out The Antibody Society's "Antibodies to Watch in 2025" webinar on February 4th!

Just - Evotec Biologics is at the forefront of biomanufacturing innovation with its JP3 platform. By integrating intensified perfusion cell culture and fully connected downstream processing, we achieve remarkable productivity and cost efficiency. Our approach not only boosts output but also ensures consistent, high-quality biotherapeutics. Leveraging AI/ML technologies and advanced process intensification, Just - Evotec Biologics is setting new industry standards. Our continuous manufacturing process significantly reduces costs and expands global access to essential biotherapeutics. Learn more- https://hubs.ly/Q032ZcsB0 #Biomanufacturing #Innovation #ContinuousManufacturing #Biotech

We're excited to announce that Jeremiah Genest, Senior Director of Quality Technical and Risk Services at Just - Evotec Biologics, will be presenting on "Implementing ASTM E2500 in Continuous Manufacturing". Date: Monday, 27 January Time: 11:15 - 11:45 Location: San Francisco, CA In this insightful session, Jeremiah will delve into the application of ASTM E2500 in the context of continuous manufacturing for monoclonal antibodies. He will discuss the unique challenges and opportunities of adapting this standard to continuous bioprocessing and share how Just - Evotec Biologics has successfully implemented it in constructing two mAb manufacturing facilities. This presentation is a must-attend for biopharmaceutical professionals involved in facility design, quality assurance, and regulatory compliance. Gain valuable insights on leveraging ASTM E2500 to enhance the efficiency and quality of continuous mAb manufacturing processes. Arrange a meeting with us here- https://hubs.ly/Q033vVWn0 #Biopharmaceuticals #ContinuousManufacturing #ASTME2500 #QualityAssurance #Bioprocessing #JustEvotecBiologics #ISPEFacilitiesOfTheFuture

Optimize your therapeutic antibodies with Just – Evotec Biologics. Are you looking to enhance the developability of your therapeutic antibodies? Discover how Just – Evotec Biologics Molecular Optimization services can help you achieve superior results. Our cutting-edge J . MD™ technologies and expert team are dedicated to optimizing your antibodies for better efficacy and safety. Why choose Just – Evotec Biologics? - AI & ML tools predict the best molecules and conditions for development - Antibody engineering techniques to humanize and optimize antibody sequences - Comprehensive developability assessments Don’t miss out on the opportunity to take your therapeutic antibodies to the next level. Learn more about our services and how we can support your research and development efforts. Learn more: https://hubs.ly/Q02VH86d0 #Biotech #Biotechnology #Biologics

Evotec SE announced that, together with Yonsei University and the Korean biotech company Zymedi, it will receive a US$ 4.5m grant from the Korea Institute of Advanced Technology (KIAT). The KIAT grant will fund the development of first-in-class biologic therapies to treat lung diseases, including asthma and idiopathic pulmonary fibrosis (IPF). The project will focus on the preclinical development of novel anti-inflammatory and anti-fibrotic antibodies directed against tRNA synthetases, an emerging therapeutic target class to treat diseases with a high unmet medical need. Read the full press release to learn more- https://hubs.ly/Q033hYsR0 #TogetherForMedicinesThatMatter #Antibody #LungDiseases #AntiInflammatory #AntiFibrotic

We are thrilled to invite you to watch an exclusive interview with Sarah Maxfield, SVP of Business Development at Just - Evotec Biologics. In this insightful discussion, Sarah explores the groundbreaking advancements at our new J.POD Toulouse biomanufacturing facility. Learn how this state-of-the-art facility is set to revolutionize the production of antibodies and related biotherapeutics, ensuring greater efficiency and flexibility. Recorded at CPHI 2024 in Milan, this interview is a must-watch for anyone interested in the future of biomanufacturing and innovative therapeutic solutions. Watch the Interview Now: https://hubs.ly/Q02_BGMT0 #Biomanufacturing #Biotherapeutics #Innovation #CPHI2024 #JustEvotecBiologics #JPODToulouse

Your Biotherapeutic Discovery: Our First-In-Human Biomanufacturing Experience Just – Evotec Biologics seamlessly integrates services to deliver flexible first-in-human (FIH) programs, supporting our partners from candidate selection to successful Investigative New Drug (IND) submission. We have a proven track record with a range of biotherapeutics including monoclonal antibodies and innovative antibody formats such as bispecifics and Fc-fusion proteins. Our expert scientists and regulatory team are dedicated to guiding our partners to regulatory success. Learn more about our first-in-human services here- https://hubs.ly/Q032d1Hh0 #FIH #First-in-human #Biologics #Biomanufacturing #Antibody

Are you ready to take your biologics from concept to clinic? At Just - Evotec Biologics, we understand the unique challenges you face in the journey to first-in-human trials. That’s why we’ve launched our new webpage dedicated to Integrated Services for First-in-Human Biologics. Why choose Just - Evotec Biologics? - Comprehensive support from discovery to clinical trials - Cutting-edge technology and expertise - Tailored solutions to accelerate your development process Visit our new webpage to learn how we can partner with you to bring your innovative therapies to patients faster and more efficiently. Explore our integrated services: https://hubs.ly/Q02ZZ3Gp0 Your discovery: Our dedication. #Biotech #FirstInHuman #ClinicalTrials #Healthcare

Just - Evotec Biologics has taken a significant step towards leveraging AI and ML for biopharmaceutical discovery by creating a Humanoid Antibody Library. In our latest publication, we describe the validation of this library by isolating antibodies against a target of pandemic concern, SARS-CoV-2. We successfully identified a panel of human monoclonal antibodies that are novel, diverse, and pharmacologically active. These first-generation antibodies exhibited neutralization of SARS-CoV-2 viral infectivity across multiple strains and indicated high developability potential. These results demonstrate the applicability of our platform for effective therapeutic antibody discovery. Read more here- https://hubs.ly/Q02SjWrX0 #MachineLearning #AI #Biopharmaceuticals #Therapeutics #SARSCoV2 #AntibodyDiscovery #JustEvotecBiologics